PCSA: CVI Investments Reports 200,000-Share Position
Processa Pharmaceuticals filed an amendment to a Schedule 13G/A reporting that CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. beneficially own 200,000 shares of common stock, representing 7.0% of the class.
Rhea-AI Filing Summary
Processa Pharmaceuticals filed an amendment to a Schedule 13G/A reporting that CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. beneficially own 200,000 shares of common stock, representing 7.0% of the class. The filing notes these shares consist of warrants and cites 2,677,835 Shares outstanding as of March 31, 2026.
The joint filing clarifies that Heights Capital Management serves as investment manager to CVI Investments and may exercise voting and dispositive power; both Reporting Persons disclaim beneficial ownership except for pecuniary interest. Signatures are dated May 13, 2026.
Positive
- None.
Negative
- None.
Insights
CVI reports a 7.0% position via warrants totaling 200,000 shares.
The filing states CVI Investments, Inc. beneficially owns 200,000 shares, and that the holdings "consist of Shares issuable upon the exercise of warrants." This identifies the economic exposure as derivative-based rather than from open-market purchases.
Changes in voting or disposition depend on exercise decisions by warrant holders and any manager-directed actions; subsequent transactions would appear in later filings if warrants are exercised or shares sold.
Heights Capital is disclosed as investment manager with shared voting/dispositive power.
The disclosure explains Heights Capital Management, Inc. may exercise voting and dispositive power over the shares owned by CVI Investments, Inc., and that Heights acts under a Limited Power of Attorney previously filed. The entities disclaim beneficial ownership except for pecuniary interest.
Corporate actions tied to these shares will follow manager decisions; any transfer of control or vote will be traceable through subsequent SEC reports.
Key Figures
Key Terms
beneficially owned regulatory
warrants financial
Limited Power of Attorney legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does CVI Investments report in Processa Pharmaceuticals (PCSA)?
When was the Schedule 13G/A amendment for PCSA signed?
What legal authority is noted for Heights acting on behalf of CVI?
AI-generated analysis. How Rhea-AI works. Not financial advice.